The Evolution of Savile Row: A Tale of Tailoring and Weight-Loss Drugs
The iconic Savile Row, renowned for its bespoke tailoring, is experiencing a transformation as weight-loss drugs gain popularity. This phenomenon is reshaping the industry, particularly among the elite clients of London's master tailors. The story begins with Kathryn Sargent, the first female master tailor in Britain, who has noticed a subtle shift in her clients' habits. When meeting new clients, she now inquires about their dietary habits and exercise routines, but an intriguing new question has emerged: 'Do you dress to the left or the right, sir?' This question hints at the impact of weight-loss drugs, as clients often reveal their use of appetite suppressants like Ozempic or Mounjaro.
Caroline Andrew, another esteemed female tailor, shares a similar experience. American clients openly discuss their weight-loss journeys, while British clients tend to downplay their sudden size reductions, attributing it to healthier eating habits. However, the truth is more complex. As wealthy consumers embrace weight-loss drugs, the demand for bespoke tailoring soars, benefiting businesses like Gormley & Gamble, where a quarter of clients are on these medications.
The impact on tailoring is profound. Tailors are now crafting suits with increased seam allowances and side adjusters to accommodate potential weight fluctuations. The cut of jackets is evolving to reflect the new posture of clients, creating a more powerful and upright silhouette. This trend is not limited to men; women are also embracing the new styles, aiming for sizes 10-12 or 48-52 on the Italian scale.
Jemma Hunt, a business partner at Gormley & Gamble, observes that many clients are investing in new suits and experimenting with fabrics. Some existing customers are replacing old suits with smaller sizes, while others opt for a more cinched waist or double-breasted jackets to enhance their new figures. The color palette is also shifting, with brighter, more vibrant hues replacing the traditional dark, slimming shades.
The business model is adapting to this new reality. Andrew advises clients to invest in slightly larger suits, anticipating potential weight regain. She suggests offering two pairs of trousers with each suit, one with a flat-fronted, fitted design and another with pleats for a more accommodating fit. This flexibility caters to the 5-8 kg weight range.
However, the rise of weight-loss drugs is not without controversy. Critics raise concerns about long-term health risks, and some users experience chronic nausea. The financial burden of these drugs, costing up to £400 monthly, adds to the debate. Despite these controversies, tailors remain non-judgmental, understanding the desire for self-improvement and the pressure to maintain a certain image.
The fashion industry, too, is influenced by this trend. The catwalk is witnessing a resurgence of low-rise trousers and prominent hip bones, a trend linked to the use of Ozempic. This shift raises questions about body positivity and the industry's commitment to diversity. As tailors adapt to this new landscape, they must navigate the delicate balance between embracing change and preserving the timeless art of bespoke tailoring.
